Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -7.08% | +2.46% | +26.26% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 31/01/16 |
Andrew Slee
COO | Chief Operating Officer | 74 | 31/01/16 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 11/02/16 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 02/02/94 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 11/02/16 |
Brian Corvese
BRD | Director/Board Member | 67 | 27/07/17 |
Khalil Barrage
BRD | Director/Board Member | 59 | 30/06/07 |
Timothy Wright
BRD | Director/Board Member | 66 | 22/11/22 |
Jennifer Buell
BRD | Director/Board Member | 50 | 17/07/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,435,132 | 3,466,915 ( 78.17 %) | 0 | 78.17 % |
Company contact information
Protagenic Therapeutics, Inc.
149 Fifth Avenue Suite 500
10010, New York
+212 994 8200
http://www.protagenic.comSector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.26% | 5.97M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- PTIX Stock
- Company Protagenic Therapeutics, Inc.